Cleveland-based Abeona Therapeutics Inc. (Nasdaq: ABEO) announced Tuesday, April 29, that it has received U.S. Food and Drug Administration (FDA) approval for a cell-based gene therapy that treats a ...

Home-price gains in the U.S. eased in February as more properties came up for sale. But gains in Cleveland outpaced those ...